- Investing.com
Metrics to compare | 214370 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship214370PeersSector | |
|---|---|---|---|---|
P/E Ratio | 116.3x | 8.3x | −0.3x | |
PEG Ratio | −4.71 | 0.13 | 0.00 | |
Price/Book | 12.7x | 0.8x | 2.6x | |
Price / LTM Sales | 36.6x | 0.5x | 3.0x | |
Upside (Analyst Target) | - | 70.9% | 56.6% | |
Fair Value Upside | Unlock | 23.3% | 10.2% | Unlock |
Caregen Co., Ltd., a biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide. The company offers filler products under the REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG Styler 600 names; skin care products under the Dermaheal, PURILUX whitening, Pim-Pim-Paul, and Neovert names; scalp care products under the Renokin and Pelo Baum names; and healthy foods under the proGsterol name. It is also developing medicines for COVID-19 treatment, wet macular degeneration, dry macular degeneration, antiviral drugs, diabetic retinopathy, cataract, hyperhidrosis, pain relief, hair loss, obesity, psoriasis, wound, arthritis, and rhinitis; medical equipment for facial beauty, scalp/hair improvement, body care, and arthritis; cosmetics for wrinkle improvement, whitening, scalp/hair improvement, acne care, UV protection, atopy improvement, fine dust blocking, dark circles, cellulite reduction, and sebum secretion control; and food for blood sugar control, improved liver function, hangover cure, cholesterol control, and body fat reduction. Caregen Co., Ltd. was founded in 2001 and is based in Anyang-Si, South Korea.